Related Experiment Video
Updated: Apr 27, 2026
15:07
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
26.3K
Simultaneous occurrence of two B-cell malignancies: A case report.
Shujuan Zhou1, Yongyong Ma1, Laixi Bi1
1Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
Oncology Letters
|July 12, 2014
Summary
This study reports a rare case of a 75-year-old male with simultaneous multiple myeloma and diffuse large B-cell lymphoma. Successful treatment was achieved using the DCEP regimen, highlighting a viable therapeutic option for this uncommon dual hematological malignancy.
Area of Science:
- Hematology
- Oncology
- Clinical Case Studies
Background:
- Multiple myeloma and diffuse large B-cell lymphoma are distinct mature B-cell neoplasms.
- These hematological malignancies typically present with different clinical features and require varied treatment strategies.
- The simultaneous occurrence of these two B-cell tumors is exceptionally rare.
Purpose of the Study:
- To describe a unique case of a patient diagnosed with concurrent multiple myeloma and diffuse large B-cell lymphoma.
- To report the successful management of this rare dual hematological malignancy.
- To contribute to the understanding of treating coexisting B-cell neoplasms.
Main Methods:
- A case study approach was employed.
- The patient was treated with the DCEP chemotherapy regimen.
- Diagnostic evaluation included standard hematological and oncological assessments.
Main Results:
- The patient presented with simultaneous multiple myeloma and diffuse large B-cell lymphoma.
- Successful treatment outcomes were observed with the DCEP regimen.
- The case highlights the feasibility of managing coexisting mature B-cell neoplasms.
Conclusions:
- Simultaneous presentation of multiple myeloma and diffuse large B-cell lymphoma is a rare clinical event.
- The DCEP regimen can be an effective treatment for patients with this rare dual hematological malignancy.
- Further research may explore optimal therapeutic strategies for coexisting B-cell neoplasms.
